THEME: "Advancing Global Health Through Innovative Nursing Education and Practice"
General Faculty Hospital, Czech Republic
Title: Concept of a New Nursing Section with additive benefits for the quality of care for pediatric patients in the Czech Republic
Pavla Pokorna, MD, PhD, is a Czech neonatologist and paediatrician based at the General Faculty Hospital and 1st Faculty of Medicine, Charles University in Prague. She graduated in medicine in 1992 and later specialized in paediatrics, neonatology, and intensive care. She earned her PhD in 2014, focusing on antibiotic pharmacology in neonates. With international training in Switzerland, Germany, and the Netherlands, she also teaches paediatrics and pharmacology. Dr. Pokorna is an active member of several medical societies and co-chairs the pharmacology section of ESPNIC
Introduction: The nursing section established by the Czech
Pediatric Society of the Czech Medical Society of Jan Evangelista Purkinje was
established at the beginning of this year. The section brings together
non-medical healthcare professionals caring for pediatric patients. It is
intended for all members of a multidisciplinary team including general and
pediatric nurses, paramedics, nutritional therapists, rehabilitation workers,
social workers and others who are involved in the care of a pediatric patient.
Aim: of the new nursing section is to strength
multidisciplinary cooperation in providing care for pediatric patients, including
suggestions for the education concept contribution to the creation of new
educational materials. Nurses and other non-physician healthcare professionals
in pediatrics are constantly expanding their knowledge in the field of
intensive care. In the future, a subgroup for intensive care in pediatrics will
be established and will focus on the specifics of nursing care in pediatric
intensive care. We are preparing a project with the working title "Skin
defects in pediatric patients". In the first phase, we would like to map
the occurrence of skin defects in children during hospitalization. In the next
steps, we will develop a recommended procedure that will also include a list of
medical devices suitable for the pediatric population.
Methodology: We have established cooperation with the Czech
National Centre for Pharmacotherapy (1st Faculty of Medicine) also
in line with the platform of available professional meetings (c4c –
conect4children). This is a European platform whose goal is to facilitate the
development of new drugs for the pediatric population, to create a network of
workplaces for international clinical trials. We will deal with pharmacotherapy
and analgesia from the perspective of the competencies of healthcare
professionals and build the position of "Research nurse" in the Czech
Republic. We also can cooperate with clinical centres (Czech Centre for
Personalised Pharmacotherapy in Pediatric Population at General Faculty
Hospital) at workplaces that cooperate with individual specialties on clinical
trials, and cooperation in the field of clinical trials in neonatology and
pediatrics.
Conclusion: Optimizing pharmacotherapy in pediatric
population is a challenge for the Czech platform including research nurse
initiative with a focus on research, health care, education as well as parents-patients-initiative.